HEALTH PROFESSIONALS MEDIA AREA PARTNERSHIPS CAREERS CONTACT US WORLD KNOW US RESPONSIBILITY RESEARCH MEDICINES VACCINES 1851 Dr. Ernst Christian Friedrich Schering In Berlin, Dr Ernst Christian Friedrich Schering begins to develop and market pharmaceutical products. Three years later, his company inaugurated its first production facilities. 1851 Prev Next KNOW US Who are we Our values Our history Our sites in France 2016 marked our 125th anniversary as a global healthcare leader. Today, we are at the forefront of research in tackling some of the world's most pressing health challenges, including over 30 different cancers, hepatitis C virus, Alzheimer's disease, Ebola virus, antibiotic resistant bacteria, cardio-metabolic diseases and many more. Since our inception in 1891, we have pushed the frontiers of science with the hope that the advancement of scientific knowledge would lead to major advancements for mankind. From the development of the first measles and mumps vaccines to the development of innovative drugs in HIV, hepatitis C and several cancers - to name a few, MSD has changed the world many times throughout its history. . 125th anniversary: Watch the video Discover some of the great discoveries of MSD here: 1942 First industrial production of penicillin 1948 Synthesis of the first cortisone derivative 1963 First vaccine available against measles 1965 Launch of a benchmark non-steroidal anti-inflammatory drug (Indocid ® ) 1970 Lancement d'un antibiotique de la famille des aminosides notamment utilisé dans les infections urinaires (Gentalline®) 1973 Mise à disposition d'un dermocorticoïde d'activité forte (Diprosone®) 1975 Découverte de l’ivermectine, préfigurant la mise au point du médicament contre l’onchocercose (cécité des rivières) (Mectizan®) 1984 Mise à disposition de la première pilule de troisième génération(Varnoline®) 1988 Mise sur le marché d’un médicament de référence de la classe des IEC dans l’hypertension artérielle (Renitec®) 1990 Lancement d'un antihistaminique agissant sélectivement sur les récepteurs H1 périphériques(Clarityne®) 1995 Lancement du premier médicament de la classe des antogonistes de l’angiotensine II dans l’hypertension artérielle (Losartan®) 1996 Découverte et mise à disposition de la deuxième anti-protéase dans le VIH/SIDA (Crixivan®) 1998 Mise à disposition du premier antiTNF alpha dans la maladie de Crohn (Remicade®) 2000 Lancement du premier anti-leucotriène dans l’asthme (Singulair®) 2001 Lancement du premier implant contraception (Implanon®) 2002 Lancement d’une nouvelle classe d’antifongiques (Cancidas®) 2004 Mise à disposition d'un anneau contraceptif mensuel (Nuvaring®) 2006 Discovery and production of the first vaccine against cervical cancer (Gardasil ® ) 2007 Discovery and availability of the first HIV integrase inhibitor (Isentress ® ) 2008 Launch of the first DPP-4 inhibitor, a new class of oral antidiabetic drugs (Januvia ® ) 2011 Availability of the first hepatitis C virus protease inhibitor (Victrelis ® ) 2014 Marketing of pembrolizumab in the United States and France (temporary authorization for use) in the treatment of advanced melanoma (Keytruda ® ) MEDIA AREA HEALTH PROFESSIONALS MSD GENERAL INFORMATIONS